Show simple item record

dc.contributor.authorStephens, N
dc.contributor.authorBéen, F
dc.contributor.authorSavic, D
dc.date.accessioned2022-07-25T15:22:18Z
dc.date.issued2022-06-06
dc.date.updated2022-07-25T13:38:30Z
dc.description.abstractWastewater-based epidemiology (WBE) is increasingly being recognized as a powerful tool for detecting and monitoring SARS-CoV-2 trends at a population level. This study looked to extend the use of WBE to explore the effectiveness of nonpharmaceutical interventions (NPIs) that have been used in response to COVID-19 and compare the results to the effect of such interventions on COVID-19 hospitalizations. A data-driven approach demonstrated that trends of SARS-CoV-2 RNA in wastewater, from Amsterdam and Utrecht (The Netherlands), precede hospitalizations by at least 3–9 days. Additionally, the effect of NPIs can be seen in wastewater and hospitalizations after 20 and 24 days, respectively. Changepoint analysis indicated that the closure of schools and universities significantly reduced the level of SARS-CoV-2 RNA in wastewater and COVID-19 hospitalizations. Regression modeling suggested the stay-at-home policy is an effective intervention for reducing the level of SARS-CoV-2 RNA in wastewater, whereas the closure of workplaces significantly reduced hospitalizations in both Dutch cities. This study demonstrates how WBE can be used to inform public health decisions and anticipate future strain on healthcare facilities in major cities but also indicates a need for higher temporal resolution of wastewater sampling.en_GB
dc.format.extentacsestwater.2c00071-
dc.identifier.citationPublished online 6 June 2022en_GB
dc.identifier.doihttps://doi.org/10.1021/acsestwater.2c00071
dc.identifier.urihttp://hdl.handle.net/10871/130372
dc.identifierORCID: 0000-0001-9567-9041 (Savic, Dragan)
dc.identifierScopusID: 35580202000 (Savic, Dragan)
dc.identifierResearcherID: G-2071-2012 | L-8559-2019 (Savic, Dragan)
dc.language.isoenen_GB
dc.publisherAmerican Chemical Society (ACS)en_GB
dc.rights.embargoreasonUnder embargo until 6 June 2023 in compliance with publisher policyen_GB
dc.rights© 2022 American Chemical Societyen_GB
dc.subjectPneumoniaen_GB
dc.subjectInfectious Diseasesen_GB
dc.subjectVaccine Relateden_GB
dc.subjectPreventionen_GB
dc.subjectEmerging Infectious Diseasesen_GB
dc.subjectLungen_GB
dc.subjectBiodefenseen_GB
dc.titleAn Analysis of SARS-CoV‑2 in Wastewater to Evaluate the Effectiveness of Nonpharmaceutical Interventions against COVID-19 in The Netherlandsen_GB
dc.typeArticleen_GB
dc.date.available2022-07-25T15:22:18Z
dc.identifier.issn2690-0637
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Chemical Society via the DOI in this recorden_GB
dc.identifier.eissn2690-0637
dc.identifier.journalACS ES&T Wateren_GB
dc.relation.ispartofACS ES&T Water
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2022-05-19
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2022-06-06
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-07-25T15:17:30Z
refterms.versionFCDAM
refterms.dateFOA2023-06-05T23:00:00Z
refterms.panelBen_GB
refterms.dateFirstOnline2022-06-06


Files in this item

This item appears in the following Collection(s)

Show simple item record